小分子RNA與心血管疾病ppt課件_第1頁(yè)
小分子RNA與心血管疾病ppt課件_第2頁(yè)
小分子RNA與心血管疾病ppt課件_第3頁(yè)
小分子RNA與心血管疾病ppt課件_第4頁(yè)
小分子RNA與心血管疾病ppt課件_第5頁(yè)
已閱讀5頁(yè),還剩36頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、MicroRNAs in Vascular Disease the beginning of a new taleChunxiang Zhang M.D., Ph.D.University of Medicine and Dentistry of New JerseyMiroRNAs MicroRNAs (miRNAs) are a novel class of endogenous, small, noncoding RNAs that regulate gene expression. Mature miRNAs are 18- to 24-nucleotide(nt)-long. The

2、y negatively regulate protein expression of their target mRNAs by either translation inhibition or degradation. As a group, miRNAs are estimated to regulate at least 30% of the human genes. Pathway of Genetic Information Flow and RNA “revolution 1.The standard pathway of information flow in a cell.

3、2. DNA Transcription and RNA products3. The first RNA revolution.Discovery of miRNA - The second RNA “revolutionDiscovery of RNAi. With the help of RNAi technology, two regulatory noncoding RNAs were found, interfering RNAs (siRNA) and endogenous miRNAs. The recent discoveries of RNAi and miRNA repr

4、esent the second RNA revolution (Kong et al. Genomics Proteomics Bioinformatics. 2019;3: 62-72). miRNAs and siRNAs siRNAs and miRNAs have similar mechanism for gene expression regulation. However, they are different from each other. The chief difference lies in their origins: SiRNAs are produced fro

5、m long double-stranded (bimolecular) RNAs or long hairpins, often of exogenous origin. In contrast, miRNAs are endogenous. They are encoded within the genome and come from endogenous short hairpin precursor. Therefore, miRNAs are more important because they are endogenous regulators for gene express

6、ion. Biogenesis of miRNAs and their molecular mechanism for gene regulationBiological functions of miRNAs Although only a small number from hundreds of identified miRNAs have been characterized, a growing body of exciting evidence suggests that miRNAs are important regulators for cell growth, differ

7、entiation, and apoptosis. Therefore, miRNAs could be the important endogenous regulators in normal development, physiology, as well as in disease. miRNAs in diseases Consequently, dysregulation of miRNA function may lead to human diseases. In this respect, the most exciting research area is the role

8、 of miRNAs in cancer, because cell dedifferentiation, growth, and apoptosis are important cellular events in the development of cancer. Indeed, both basic and clinical studies have demonstrated that miRNAs are aberrantly expressed in diverse cancers. The recent advances in the research of miRNAs and

9、 cancers have resulted in the following conclusions. First, the aberrant expressions of miRNAs are tissue- and cancer-specific. Different tissues and cancers have different miRNA expression profiles. Second, multiple miRNAs are dysregulated in cancers. Third,miRNAs are thought to function as both tu

10、mor suppressors and oncogenes. Fourth, miRNAs may serve as novel therapeutic targets for cancer. Therefore, identifying the detailed functions of the key aberrantly expressed miRNAs is critical for cancer research MiRNAs in cardiovascular disease Proliferative vascular disease has long been the lead

11、ing cause of death in developed countries. Although miRNAs are highly expressed in the vascular system, the roles of these miRNAs in vascular disease are unknown. As vascular disease share some similar cellular events and molecular mechanisms with cancer, we hypothesize that miRNAs may play importan

12、t roles in vascular disease. Animal Model Selection Vascular neointimal lesion formation. Neointimal formation is the common pathological lesion in atherosclerosis, restenosis, diabetic vascular complication and transplant vascular disease. Hypothesis Cell growth (proliferation) and apoptosis are ke

13、y cellular events in the formation of vascular neointimal lesion formation, whereas miRNAs are able to regulate these cellular events in other cell type. We therefore hypothesize that miRNAs may play important roles in vascular neointimal lesion formation by regulating vascular smooth muscle cell gr

14、owth and/or apoptosis. MiRNAs in vascular neointimal lesion formation We are trying to answer the following questions to determine the potential role of miRNAs in vascular neointimal formation.Question # 1: Are the miRNAs aberrantly expressed in vascular wall with neointimal lesion formation? Questi

15、on # 2: If the answer to the first question is yes, do these aberrantly expressed miRNAs play a role neointimal lesion formation? Question # 3: What are the cellular mechanisms responsible for miRNA-mediated effect on neoinimal formatiom?Question# 4: What are the molecular mechanisms responsible for

16、 miRNA-mediated effect on neoinimal formatiom? Rat carotid artery balloon injury To determine the expression changes of miRNAs in the vascular wall with neointimal formation, we applied the well-established rat carotid artery balloon injury model in my laboratory. In which, rat (Sprague-Dawley, 250-

17、300g) right common carotid artery injury was induced via a A 2F Fogarty balloon catheter. Remarkable neointimal lesion formation will be induced as early as 7 days after injury. MiRNA expression signature in normal rat carotid artery MiRNAs are aberrantly expressed in rat carotid arteries after angi

18、oplasty Compared with normal uninjured arteries, microarray analysis demonstrated that aberrant miRNA expression was a remarkable characteristic in vascular walls after angioplasty. Seven days after balloon injury, 113 of the 140 artery miRNAs were differentially expressed with p-value 0.01; 60 miRN

19、As were upregulated, and 53 miRNAs were downregulated. At 14 days after injury, 110 of the 140 artery miRNAs were differentially expressed (63 up and 47 down), while 102 of the 140 artery miRNAs were differentially expressed (55 up and 47 down) at 28 days after angioplasty. The time course changes o

20、f miRNAs that were highly expressed in rat carotid artery and over 1-fold upregulated after angioplastyThe time course changes of miRNAs that were highly expressed in rat carotid artery and over 50% downregulated after angioplastyConfirmation of the aberrant miRNA expression in injured arteries by q

21、RT-PCR and / or Northern blot analysis. Do these aberrantly expressed miRNAs play a role in vascular neointimal lesion formation? To determine the potential role of these aberrantly expressed miRNAs in neointimal formation, we selected miR-21 as our first experimental target for the following reason

22、s:miR-21 is one of the most up-regulated miRNAs after angioplasty.miR-21 is also up-regulated in diverse cancers.There is a commercially available inhibitor. miR-21 inhibitor The antisense oligonucleotide for miR-21 is modified at each nucleotide by an O-methyl moiety at the 2-ribose position. The m

23、odified antisense oligonucleotide (2OMe-miR-21) is also called miRNA inhibitor. MiR-21 inhibitor (2OMe-miR-21) was synthesized by Integrated DNA Technologies and has the following sequence and structure: 5mUmCmAmAmCmAmUmCmAmGmUmCmUmGmAmUmAmAmGmCmUmA-3. For the control purpose, we have used two contr

24、ols for this study. The first control was a vehicle control (PBS) and the second control was an irrelevant 2-O-methyl-oligonucleotide (2OMe-EGFP). 2OMe-EGFP was also synthesized by Integrated DNA Technologies and has the following sequence and structure: 5mAmAmGmGmCmAmAmGmCmUmGmAmCmCmCmUmGmAmAmGmU-3

25、.Local oligo delivery into the injured vascular wallThe effect of miR-21 on neointimal formation after angioplastyWhat are the cellular mechanisms involved in miR-21 mediated effect on neointimal formation? VSMC proliferation is the key cellular event for neointimal lesion formation. To identify the

26、 cellular mechanism involved in miR-21-mediated effect on neointimal lesion formation, we therefore determined the effect of miR-21 inhibitor 2OMe-miR-21 on cell proliferation in cultured VSMCs in the following experiments. It is well known that freshly isolated VSMCs mimic differentiated VSMCs in n

27、ormal uninjured vascular wall, whereas serum cultured VSMCs mimic dedifferentiated VSMCs in vascular neointimal lesions. We thus determined the miR-21 levels in freshly isolated, differentiated VSMCs and dedifferentiated VSMCs cultured in DMEM containing 10% FBS. We found that the expression of miR-

28、21 in dedifferentiated VSMCs was significantly higher than that in freshly isolated, differentiated VSMCs.2OMe-miR-21 decreases the miR-21 expression level in cultured VSMCs in a dose-dependent manner2OMe-miR-21 decreases VSMC proliferation in vitroRepresentative BrdU stained photomicrographs (botto

29、m panel) as well as their corresponding total cell photomicrographs (top panel)What is the effect of miR-21 on VSMC apoptosis? Neointimal growth is the balance between cell apoptosis and cell proliferation. Thus, apoptosis is also an important cellular event in neointimal lesion formation. Recent re

30、ports demonstrated that miR-21 had anti-apoptosis effect on glioblastoma cells, but had no anti-apoptosis effect on HeLa cells. Does miR-21 have anti-apoptosis effect on VSMC apoptosis? To determine the effect of miR-21 on VSMC apoptosis, we applied a well-established VSMC apoptosis model in which a

31、poptosis was measured after 48 h in serum-free culture. Apoptosis was evaluated by dUTP nick-end labeling (TUNEL) assay and caspase-3 activity measurement. The effect of miR-21 on VSMC apoptosis in vitroRepresentative TUNEL stained photomicrographs (bottom panel) as well as their corresponding total

32、 cell photomicrographs (top panel)2OMe-miR-21 decreases VSMC proliferation in vivo in balloon injured vessels2OMe-miR-21 increases VSMC apoptosis in vivo in balloon injured vesselsPotential gene targets in miR-21-mediated cellular effects on VSMCs miRNA is able to bind to its mRNA targets with eithe

33、r perfect or imperfect complementarity. Thus, one miRNA may have multiple mRNA targets. Based on the cellular effects of miR-21 on VSMCs, we proposed that miR-21 might target, degrade a tumor suppressor gene, and/or block its translation. computational analysis of miR-21 targets Computational analys

34、is suggests that PTEN, Bcl-2, and transforming growth factor-beta (TGF-beta) might be the potential target genes for miR-21. It is important that all the computational predicted miRNA targets should be verified by experimental approaches. TGF-beta is not a gene target for miR-21Bcl-2 is not a direct

35、 target of miR-21PTEN is a direct target of miR-21 Summary of the results1. miRNA expression signature in artery is identified for the first time.miRNAs are aberrantly expressed in the vascular walls with neointimal lesion formation.Modulating an aberrantly overexpressed miRNA, miR-21, via antisense-mediated depletion (knock-down) have a significant negative effect on neointimal lesion formatio

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論